GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » Beneish M-Score

Notable Labs (Notable Labs) Beneish M-Score : 31.75 (As of May. 13, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Notable Labs Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score 31.75 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Notable Labs's Beneish M-Score or its related term are showing as below:

NTBL' s Beneish M-Score Range Over the Past 10 Years
Min: 31.75   Med: 31.75   Max: 31.75
Current: 31.75

During the past 3 years, the highest Beneish M-Score of Notable Labs was 31.75. The lowest was 31.75. And the median was 31.75.


Notable Labs Beneish M-Score Historical Data

The historical data trend for Notable Labs's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Notable Labs Beneish M-Score Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
Beneish M-Score
- - 31.75

Notable Labs Semi-Annual Data
Dec21 Dec22 Dec23
Beneish M-Score - - 31.75

Competitive Comparison of Notable Labs's Beneish M-Score

For the Biotechnology subindustry, Notable Labs's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Notable Labs's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Notable Labs's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Notable Labs's Beneish M-Score falls into.



Notable Labs Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Notable Labs for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.6+0.528 * 2.7434+0.404 * 0.282+0.892 * 38.75+0.115 * 2.9169
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.0504+4.679 * -0.048155-0.327 * 0.5971
=31.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $0.19 Mil.
Revenue was $0.31 Mil.
Gross Profit was $0.11 Mil.
Total Current Assets was $15.47 Mil.
Total Assets was $19.54 Mil.
Property, Plant and Equipment(Net PPE) was $2.35 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.26 Mil.
Selling, General, & Admin. Expense(SGA) was $10.06 Mil.
Total Current Liabilities was $2.74 Mil.
Long-Term Debt & Capital Lease Obligation was $1.53 Mil.
Net Income was $-11.26 Mil.
Gross Profit was $3.39 Mil.
Cash Flow from Operations was $-13.72 Mil.
Total Receivables was $0.01 Mil.
Revenue was $0.01 Mil.
Gross Profit was $0.01 Mil.
Total Current Assets was $2.99 Mil.
Total Assets was $5.51 Mil.
Property, Plant and Equipment(Net PPE) was $0.80 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.32 Mil.
Selling, General, & Admin. Expense(SGA) was $5.16 Mil.
Total Current Liabilities was $2.01 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0.186 / 0.31) / (0.008 / 0.008)
=0.6 / 1
=0.6

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(0.008 / 0.008) / (0.113 / 0.31)
=1 / 0.364516
=2.7434

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (15.47 + 2.347) / 19.541) / (1 - (2.988 + 0.799) / 5.511)
=0.088225 / 0.312829
=0.282

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=0.31 / 0.008
=38.75

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.323 / (0.323 + 0.799)) / (0.257 / (0.257 + 2.347))
=0.287879 / 0.098694
=2.9169

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(10.064 / 0.31) / (5.156 / 0.008)
=32.464516 / 644.5
=0.0504

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1.526 + 2.738) / 19.541) / ((0 + 2.014) / 5.511)
=0.218208 / 0.365451
=0.5971

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-11.264 - 3.393 - -13.716) / 19.541
=-0.048155

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Notable Labs has a M-score of 31.75 signals that the company is likely to be a manipulator.


Notable Labs Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Notable Labs's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Notable Labs (Notable Labs) Business Description

Traded in Other Exchanges
N/A
Address
320 Hatch Drive, Foster City, CA, USA, 94404
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic.